Loading…
Entrada Therapeutics, Inc. is projected to rise to $7.19 by 2027, a +6% move from its current price of $6.79. TRDA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $6.53 | $6.79 | $7.06 | +0.06% |
| Aug 4 | $6.43 | $6.80 | $7.18 | +0.12% |
| Aug 5 | $6.36 | $6.80 | $7.28 | +0.18% |
| Aug 6 | $6.30 | $6.81 | $7.36 | +0.24% |
| Aug 7 | $6.24 | $6.81 | $7.43 | +0.30% |
| Aug 8 | $6.19 | $6.81 | $7.50 | +0.37% |
| Aug 9 | $6.15 | $6.82 | $7.56 | +0.43% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.15 | $6.82 | $7.56 | +0.43% |
| Week 2 | $5.92 | $6.85 | $7.92 | +0.85% |
| Week 3 | $5.75 | $6.88 | $8.22 | +1.28% |
| Week 4 | $5.62 | $6.91 | $8.49 | +1.72% |
| Week 5 | $5.51 | $6.94 | $8.73 | +2.15% |
| Week 6 | $5.41 | $6.97 | $8.96 | +2.58% |
| Week 7 | $5.33 | $7.00 | $9.19 | +3.02% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible.
Its Endosomal Escape Vehicle therapeutics are based on a novel therapeutic, with a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases.
The company was formerly known as CycloPorters, Inc., and changed its name to Entrada Therapeutics, Inc., in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Entrada Therapeutics, Inc. trades under the symbol TRDA. Its current price is $6.55 and its market capitalization is $254.28M.
Its rank is 3616 in the market. The forecast suggests an overall upward price trajectory over time, with the average price rising from $6.55 in 2026 to a high-longer-term level, while sentiment shifts from Neutral in early years to Bullish in later years.
A major floor 28.2% below — a decisive break under it would weaken the trend.
The nearest floor, 14.1% below — buyers have tended to step in here.
The nearest ceiling, 14.0% above — a clean break opens room to run.
A major ceiling 136.1% above — clearing it would confirm fresh momentum.
Key TRDA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TRDA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.40 | Buy | $6.53 | Buy |
| MA 10 | $6.29 | Buy | $6.48 | Buy |
| MA 20 | $6.69 | Buy | $6.62 | Buy |
| MA 50 | $6.78 | Buy | $7.33 | Sell |
| MA 100 | $9.40 | Sell | $8.35 | Sell |
| MA 200 | $9.64 | Sell | $9.05 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.60 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 15.88 | Neutral |
| Williams %R (14) | -25.00 | Info |
| MACD (12,26,9) | 0.05 | Buy |
| ROC (12) | -4.50 | Sell |
| Bollinger %B (20,2) | 0.55 | Neutral |
| Stochastic %K (14) | 75.00 | Neutral |
| TRIX (15) | -0.49 | Sell |
| Awesome (5,34) | -0.49 | Sell |
| Ultimate (7,14,28) | 61.00 | Neutral |
| Momentum (10) | -0.10 | Sell |
| Aroon Osc (25) | -84.00 | Sell |
| Hull MA (9) | 6.69 | Buy |
| ADX (14) | 14.88 | Neutral |
| ATR (14) | 0.26 | Info |
The near-term technical picture remains NEUTRAL, with RSI14 at 50.
Near-term momentum shows SMA50 at $6.74 and SMA200 at $9.63. Support sits at $5.83 and resistance at $7.74, framing a modest trading band.
The 30-day price range is $5.00 to $8.57, reflecting modest volatility in the coming weeks.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.65 | $6.79 | $9.90 | 0% | Neutral | |
| $5.51 | $7.19 | $10.04 | +6% | Neutral | |
| $5.99 | $8.15 | $11.97 | +20% | Bullish | |
| $6.90 | $9.73 | $14.85 | +43% | Bullish | |
| $8.27 | $12.03 | $18.97 | +77% | Bullish | |
| $10.13 | $15.17 | $24.60 | +123% | Bullish | |
| $9.74 | $14.98 | $24.91 | +121% | Bullish | |
| $9.51 | $15.00 | $25.51 | +121% | Bullish | |
| $10.69 | $17.30 | $30.03 | +155% | Bullish | |
| $10.36 | $17.17 | $30.37 | +153% | Bullish | |
| $14.36 | $26.57 | $50.84 | +291% | Bullish | |
| $30.97 | $68.82 | $147.31 | +914% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $5.65 | $6.79 | $8.57 | +0.00% |
| September 2026 | $5.84 | $7.00 | $8.68 | +3.04% |
| October 2026 | $5.93 | $7.18 | $9.03 | +2.58% |
| November 2026 | $6.26 | $7.63 | $9.72 | +6.31% |
| December 2026 | $6.26 | $7.69 | $9.90 | +0.80% |
Click any year to see its month-by-month TRDA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Entrada Therapeutics, Inc.'s 2026 outlook centres on $6.79, within a $5.65 to $9.90 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, TRDA could reach as high as $10.04, with a base case around $7.19 and support toward $5.51 — roughly +6% from $6.79. A consolidation phase looks the most probable path here.
Expect TRDA to range from $5.99 to $11.97 through 2028. The $8.15 average target implies a +20% move from current prices. That is up +13% on the projected 2027 average. Momentum favours further upside here.
The TRDA price prediction for 2029 points to an average of $9.73 (low $6.90, high $14.85) — a potential gain of +43% on today's $6.79. Buyers look set to stay in control over this stretch.
In 2030, TRDA is projected to trade between $8.27 and $18.97, averaging $12.03 — a potential gain of +77% from today's $6.79. That is up +24% on the projected 2029 average. Momentum favours further upside here.
Entrada Therapeutics, Inc.'s 2031 outlook centres on $15.17, within a $10.13 to $24.60 range. That is up +26% on the projected 2030 average. That marks a +123% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, TRDA could reach as high as $24.91, with a base case around $14.98 and support toward $9.74 — roughly +121% from $6.79. Momentum favours further upside here.
Expect TRDA to range from $9.51 to $25.51 through 2033. The $15.00 average target implies a +121% move from current prices. That is up 0% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The TRDA price prediction for 2034 points to an average of $17.30 (low $10.69, high $30.03) — a potential gain of +155% on today's $6.79. Momentum favours further upside here.
In 2035, TRDA is projected to trade between $10.36 and $30.37, averaging $17.17 — a potential gain of +153% from today's $6.79. That is -1% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
Entrada Therapeutics, Inc.'s 2040 outlook centres on $26.57, within a $14.36 to $50.84 range. That is up +55% on the projected 2035 average. That marks a +291% change versus current levels. Momentum favours further upside here.
By 2050, TRDA could reach as high as $147.31, with a base case around $68.82 and support toward $30.97 — roughly +914% from $6.79. Buyers look set to stay in control over this stretch.
Investing $1,000 in TRDA today (≈ 147.275405 TRDA) could be worth
$10,135.38
+$9,135.38 (+914%) by 2050 · US Dollar
Based on the average projected TRDA price of $68.82 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TRDAwould be worth at today's price.
$1,000 invested in TRDA on Jul 31, 2025 (≈ 170.068024 TRDA) would be worth
$1,154.76
+$154.76 (+15.5%) today · 1.15× · US Dollar
Based on a TRDA entry price of $5.88 vs. today's $6.79.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.85 | $1,160.68 | +16.1% |
| 1 month ago | $7.59 | $894.6 | -10.5% |
| 3 months ago | $14.5 | $468.28 | -53.2% |
| 6 months ago | $11.85 | $573 | -42.7% |
| 1 year ago | $5.88 | $1,154.76 | +15.5% |
| All time (4.8y) ago | $23.95 | $283.51 | -71.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TRDA forecast.
Our base-case forecast reaches $14.00 around 2031.
Implied market cap at $14.00: $543.49M
The multi-year forecast shows the average price rising from $6.55 in 2026 to $57.59 in 2050, with the upside path broadening over time. The forecast indicates a bullish sentiment in later years, with key milestones such as 2030 (avg $10.84, ROI 65.4%), 2040 (avg $22.66, ROI 245.9%), and 2050 (avg $57.59, ROI 779.3%). The 2029-2035 period also shows rising averages and positive ROI, culminating in strong upside by 2050.
These figures reflect estimates and are not guarantees; market conditions and other factors can cause actual results to differ.
Tap a question to reveal the answer.
In 2030, the average forecast price is $10.84, with a min of $7.35 and a max of $17.31; the projected ROI is 65.4% and sentiment is BULLISH.
Forecasts show a path from a current price of $6.55 toward higher averages, with 2030 avg $10.84 and 2050 avg $57.59, and multiple years of bullish sentiment. These are estimates, not guarantees, and depend on market conditions.
The forecast contains a 2050 max of $126.01 and a 2050 avg of $57.59, indicating potential for price levels above $50 by 2050, though earlier years show lower mids. These are not guarantees.
Current price is $6.55 and market cap is $254.28M.
The 30-day range is $5.00 to $8.57, with support at $5.83 and resistance at $7.74; RSI 14 is 50.
Entrada Therapeutics, Inc. Community Discussion
0Share your Entrada Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.